• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
International Journal of Pediatrics
Articles in Press
Current Issue
Journal Archive
Volume Volume 7 (2019)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 6 (2018)
Volume Volume 5 (2017)
Volume Volume 4 (2016)
Volume Volume 3 (2015)
Volume Volume 2 (2014)
Volume Volume 1 (2013)
International Journal of Pediatrics
Rejection Rate 71.93%
Alebrahim, Z., Moayedi, A., Nazemi, A., Madani, A., Montaseri, M. (2019). Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial. International Journal of Pediatrics, 7(1), 8907-8913. doi: 10.22038/ijp.2018.34534.3036
Zahra Alebrahim; Ali Reza Moayedi; Abdolmajid Nazemi; Abdolhossein Madani; Maryam Montaseri. "Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial". International Journal of Pediatrics, 7, 1, 2019, 8907-8913. doi: 10.22038/ijp.2018.34534.3036
Alebrahim, Z., Moayedi, A., Nazemi, A., Madani, A., Montaseri, M. (2019). 'Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial', International Journal of Pediatrics, 7(1), pp. 8907-8913. doi: 10.22038/ijp.2018.34534.3036
Alebrahim, Z., Moayedi, A., Nazemi, A., Madani, A., Montaseri, M. Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial. International Journal of Pediatrics, 2019; 7(1): 8907-8913. doi: 10.22038/ijp.2018.34534.3036

Prophylactic Efficacy of Cinnarizine versus Propranolol in the Treatment of Childhood Migraine: A Single-Blind Randomized Clinical Trial

Article 15, Volume 7, Issue 1 - Serial Number 61, January 2019, Page 8907-8913  XML PDF (579 K)
DOI: 10.22038/ijp.2018.34534.3036
Authors
Zahra Alebrahim1; Ali Reza Moayedi orcid 1; Abdolmajid Nazemi1; Abdolhossein Madani2; Maryam Montaseri2
1Department of Pediatrics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
2Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Abstract
Background
Although the development of effective and safe treatments for prophylaxis of migraine headaches represents an important public health concern, only a few medications have been approved by the specific treatment of patients with migraine. We aimed to compare the efficacy of cinnarizine with propranolol in the prophylaxis of pediatric migraine headache.
Materials and Methods
 In a Randomized Clinical Trial, children aged 6-14 years were selected from the patients with migraine admitted to the neurology clinic of Bandar Abbas pediatric Hospital, affiliated to Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Eligible patients (n, 56) were randomly divided into two groups, each comprising 28 patients: the first group administered cinnarizine (37.5 mg/day in children aged 6–12 years and 50 mg/day in children aged 12–17 years), and the second group received propranolol (1-mg/kg/day). The frequency, severity of headaches over the trial period were assessed.  
Results: After two months of treatment, both groups had significant reduction in headache frequency in comparison with baseline period (p= 0.047), although this difference between groups was not statistically significant. In addition, the mean severe migraine attacks at the end of the second month was significantly lower in the cinnarizine group compared with the propranolol group (p=0.048).  At the end of the study 64% (n=18) of patients who had received the cinnarizine and 57% (n=16) of patients who had administered the propranolol, the drugs appeared to have a preventative effect on their headaches.
Conclusion: According to the results, Cinnarizine appeared as effective as propranolol for the prophylactic treatment of childhood migraine.
Keywords
Children; Cinnarizine; Headache; Migraine; Propranolol
Statistics
Article View: 175
PDF Download: 191
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.